PHGE

PHGE

USD

BiomX Inc. COmmon Stock

$0.440-0.020 (-4.348%)

リアルタイム価格

Healthcare
バイオテクノロジー
イスラエル

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$0.460

高値

$0.463

安値

$0.435

出来高

0.13M

企業ファンダメンタルズ

時価総額

11.5M

業種

バイオテクノロジー

Israel

取引統計

平均出来高

0.13M

取引所

ASE

通貨

USD

52週レンジ

安値 $0.43現在値 $0.440高値 $3.86

関連ニュース

GlobeNewswire

BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference

NESS ZIONA, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic

もっと見る
BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on BiomX, Lowers Price Target to $15

HC Wainwright & Co. analyst Joseph Pantginis maintains BiomX with a Buy and lowers the price target from $21 to $15.

もっと見る
HC Wainwright & Co. Maintains Buy on BiomX, Lowers Price Target to $15
GlobeNewswire

BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates

In March 2025, BiomX announced positive topline results of the phase 2 trial evaluating BX211 for the treatment of diabetic foot osteomyelitis (DFO) BX004 Phase 2b study in Cystic Fibrosis (CF) on track to report

もっと見る
BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates
GlobeNewswire

BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025

NESS ZIONA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic

もっと見る
BiomX to Host First Quarter 2025 Financial Results Conference Call and Webcast on May 15, 2025

最新情報を入手

価格アラートを設定し、AI分析の更新とリアルタイム市場ニュースを受け取る。